Labor and Delivery Implant Insertion: A Randomized Controlled Trial

• Status: Completed
• Trial end date: 2021-07-31
• Target enrollment: 0
• Participant gender: Female

Summary

A barrier to initiating progestin contraceptives in the early postpartum period is the concern of interference with breastfeeding, specifically lactogenesis. In this trial, the investigators aim to describe the effects of immediate insertion of the contraceptive implant on breastfeeding. The investigators seek to examine the time to lactogenesis with immediate post-delivery insertion in delivery room versus insertion of a contraceptive implant in the postpartum ward prior to medical discharge. For this study, 82 consenting women will be randomized to immediate implant insertion (0-2 hours following delivery) in the delivery room or insertion of the implant following delivery in postpartum room and prior to medical discharge (24-48 hours following delivery).

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Stanford University
• Treatments: Contraceptive Agents; Desogestrel; Etonogestrel; Polystyrene sulfonic acid

Criteria

Inclusion Criteria:

• Pregnant women who are patients of the Stanford University Obstetrics service

• Pregnant women who delivery a healthy infant, regardless of gestational age.

• Intend to breastfeed

• Desire the contraceptive implant as their method of contraception

• Agree to be randomized to delivery room vs. postpartum ward insertion

Exclusion Criteria:

• Not English or Spanish speaking

• Allergy or Contraindication to contraceptive implant.